dalteparin has been researched along with Tongue Neoplasms in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Tongue Neoplasms: Tumors or cancer of the TONGUE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, TJ | 1 |
| Khan, SA | 1 |
1 other study available for dalteparin and Tongue Neoplasms
| Article | Year |
|---|---|
Large saddle embolus during cancer therapy.
Topics: Aged; Anticoagulants; Carcinoma, Squamous Cell; Chemoradiotherapy; Enoxaparin; Humans; Male; Pulmona | 2016 |